Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Biochimica Et Biophysica Acta|December 21, 2010
Special issue on molecular basis of multiple sclerosisAlexandre Prat
Cold Spring Harbor Perspectives in Biology|January 7, 2015
The blood-brain barrierRichard Daneman, Alexandre Prat
Science Translational Medicine|November 8, 2023
CNS therapeutics: Immune cells break the barriersKarine Thai, Alexandre Prat
The Lancet. Neurology|January 10, 2012
Firategrast: natalizumab in a pill?Alexandre Prat, Olaf Stüve
Current Opinion in Neurology|May 14, 2005
Pathogenesis of multiple sclerosisAlexandre Prat, Jack Antel
Annals of Translational Medicine|February 9, 2016
One more role for the gut: microbiota and blood brain barrierLaure Michel, Alexandre Prat
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
How safe is natalizumab during pregnancy?Pierre Duquette, Alexandre Prat
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
A roadmap to precision medicine for multiple sclerosisTanuja Chitnis, Alexandre Prat
Presse Medicale (Paris, France : 1983)|March 28, 2015
Update on treatments in multiple sclerosisLaure Michel, Catherine Larochelle, Alexandre Prat
The Lancet. Neurology|December 15, 2023
Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapiesBettina Zierfuss, Catherine Larochelle, Alexandre Prat
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Biochimica Et Biophysica Acta|December 21, 2010
Special issue on molecular basis of multiple sclerosisAlexandre Prat
Cold Spring Harbor Perspectives in Biology|January 7, 2015
The blood-brain barrierRichard Daneman, Alexandre Prat
Science Translational Medicine|November 8, 2023
CNS therapeutics: Immune cells break the barriersKarine Thai, Alexandre Prat
The Lancet. Neurology|January 10, 2012
Firategrast: natalizumab in a pill?Alexandre Prat, Olaf Stüve
Current Opinion in Neurology|May 14, 2005
Pathogenesis of multiple sclerosisAlexandre Prat, Jack Antel
Annals of Translational Medicine|February 9, 2016
One more role for the gut: microbiota and blood brain barrierLaure Michel, Alexandre Prat
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
How safe is natalizumab during pregnancy?Pierre Duquette, Alexandre Prat
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
A roadmap to precision medicine for multiple sclerosisTanuja Chitnis, Alexandre Prat
Presse Medicale (Paris, France : 1983)|March 28, 2015
Update on treatments in multiple sclerosisLaure Michel, Catherine Larochelle, Alexandre Prat
The Lancet. Neurology|December 15, 2023
Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapiesBettina Zierfuss, Catherine Larochelle, Alexandre Prat
Pageof 27